Oxygen Biotherapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 46   

Articles published

OXBT 4.10 +0.04 (0.99%)
price chart
Trader's Alert - Twitter Inc (NYSE:TWTR), Oxygen Biotherapeutics, Inc. (NASDAQ ...
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) the biotechnology company late Thursday said it chose to stop its Phase IIb trial of its Oxycyte drug candidate for traumatic brain injury and will consider strategic alternatives for the program moving forward.
Oxygen Biotherapeutics Announces Halt of Oxycyte Phase IIb Traumatic Brain ...  MarketWatch
Related articles »  
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics ...
MORRISVILLE, N.C., Sep 16, 2014 (BUSINESS WIRE) -- Oxygen Biotherapeutics, Inc. OXBT, +0.99% a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that ...
Related articles »  
Watch List: Ford Motor (NYSE:F), Exelixis (NASDAQ:EXEL), Oxygen ...
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced that the Company, with unanimous approval from the Board of ...
Stocks in Focus: Oxygen Biotherapeutics (NASDAQ:OXBT), Vitesse ...
On September Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) announced that the Company, with unanimous approval from the Board of Directors, has elected to stop the current Phase IIb trial for its Oxycyte drug candidate and consider strategic alternatives ...
Hot Watch List: NanoString Technologies, Inc. (NASDAQ:NSTG), Oxygen ...
On 7 AUG Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) announced that John Kelley Chief Executive Officer will present a company overview at the Wedbush 2014 Life Sciences Management Access Conference at Le Parker Meridien in New York on ...
Active Stocks : Guidance Software (NASDAQ:GUID), Oxygen Biotherapeutics ...
On AUG 6, Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced a collaboration with Imperial College London to provide ...
Related articles »  
Hot News : Facebook Inc (NASDAQ:FB), Oxygen Biotherapeutics (NASDAQ ...
Morrisville drug developer Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) will grant $500,000 to Imperial College London to advance a study on a potential new drug that could benefit Oxygen in the future.
Momentum Stocks: Southwest Airlines Co. (NYSE:LUV), Oxygen Biotherapeutics ...
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, on 6 August announced a collaboration with Imperial College London to ...
Related articles »  
Active Stocks: Oxygen Biotherapeutics (NASDAQ:OXBT), Ampio ...
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, on 6 August announced a collaboration with Imperial College London to ...
Hot Alert : Coronado Biosciences (NASDAQ:CNDO), Repros Therapeutics Inc ...
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a pharmaceutical company specializing on critical care products, will partner with Imperial College London to supply additional funding in an ongoing Phase III trial investigating levosimendan in cardiac ...